HealthEquity, Inc. (NASDAQ:HQY – Get Free Report) has earned an average recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, twelve have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $111.7857.
HQY has been the topic of a number of research reports. Barclays reduced their price target on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating on the stock in a report on Wednesday, February 18th. Wall Street Zen downgraded shares of HealthEquity from a “buy” rating to a “hold” rating in a report on Saturday, May 9th. BMO Capital Markets upgraded shares of HealthEquity from a “market perform” rating to an “outperform” rating and boosted their target price for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. Deutsche Bank Aktiengesellschaft boosted their target price on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Finally, Barrington Research restated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd.
Read Our Latest Analysis on HQY
HealthEquity Stock Performance
HealthEquity (NASDAQ:HQY – Get Free Report) last announced its quarterly earnings results on Tuesday, March 17th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.05. The company had revenue of $334.59 million for the quarter, compared to the consensus estimate of $332.48 million. HealthEquity had a net margin of 16.39% and a return on equity of 13.86%. The firm’s quarterly revenue was up 7.3% on a year-over-year basis. As a group, analysts anticipate that HealthEquity will post 3.84 EPS for the current fiscal year.
Institutional Trading of HealthEquity
Large investors have recently made changes to their positions in the business. Acumen Wealth Advisors LLC bought a new stake in shares of HealthEquity in the 4th quarter worth about $27,000. Caitong International Asset Management Co. Ltd increased its holdings in shares of HealthEquity by 1,723.5% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 310 shares of the company’s stock worth $28,000 after buying an additional 293 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new stake in shares of HealthEquity in the 4th quarter worth about $28,000. Leonteq Securities AG boosted its stake in shares of HealthEquity by 159.9% during the 1st quarter. Leonteq Securities AG now owns 382 shares of the company’s stock worth $32,000 after purchasing an additional 235 shares during the period. Finally, Axiom Investment Management LLC bought a new position in HealthEquity during the 1st quarter valued at about $33,000. 99.55% of the stock is currently owned by institutional investors.
About HealthEquity
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
